Two leading health systems are taking markedly different approaches to cutting clinical variation, which can hinder care quality and drive up costs when left unchecked. Variation in clinical care ...

Gain insights into Chemed Corporation's Q1 2025 performance, with VITAS growth, strategic Medicare Cap solutions, and Roto-Rooter's revenue recovery outlined.

Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

ACTO, the only AI-powered Intelligent Field Excellence (IFE) platform purpose-built for the life sciences industry, and ScienceMedia, the pioneer in scientifically validated clinical training, today ...

We published the book "Demystifying Psychiatry" in 2010. Although basic principles of psychiatric treatment remain unchanged, ...

Between 2021 and 2024, the share of spine surgeries performed in the ASC setting has grown 8% year over year nationwide, but one ASC is doubling that volume. Gautier, Miss.-based Bienville Orthopaedic ...

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting ...

Arcellx Inc. company and executive profile by Barron's. View the latest ACLX company infomation and executive bios.

CompanyOverview|NASDAQ:CLLS] Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing 'off-the-shelf' cancer immunotherapies using gene-editing technology.

Startup Brellium built an artificial-intelligence-powered solution that helps providers automate clinical quality and payer ...

AbbVie is a popular stock with dividend investors for its high starting yield and continuous dividend increases. AbbVie is a ...

Iovance Biotherapeutics (NASDAQ: IOVA) is one such company right now, entering a decade of incredible growth. Here's why ...